A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.
Silva lining for Tech City’s future
2 August 2013
By Stephen Caddick, University College London
In 10 Downing Street’s Rose Garden a few weeks ago, Rohan Silva, the architect of Tech City, said goodbye to his formal role in Government and, with that, an extraordinary period in the development of East London.